| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |